Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs
The ability to support a comprehensive vaccine research and development (R&D) portfolio from a health security perspective has taken on enhanced significance over the past 3 years whereby countries that had existing vaccine R&D infrastructure (G7, Russia and China) have been at the f...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-03-01
|
| Series: | Frontiers in Public Health |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2023.1143790/full |
| _version_ | 1811161703294959616 |
|---|---|
| author | Jonathan Hare Giovanna Riggall Alexander Bongers Kirthi Ramesh Larissa Kokareva Brian Chin |
| author_facet | Jonathan Hare Giovanna Riggall Alexander Bongers Kirthi Ramesh Larissa Kokareva Brian Chin |
| author_sort | Jonathan Hare |
| collection | DOAJ |
| description | The ability to support a comprehensive vaccine research and development (R&D) portfolio from a health security perspective has taken on enhanced significance over the past 3 years whereby countries that had existing vaccine R&D infrastructure (G7, Russia and China) have been at the forefront of global efforts to combat COVID-19. Few countries outside of these key players have the infrastructure necessary to develop national vaccine programs, though this is beginning to change with investment across many low- and middle-income countries. These same opportunities exist for countries in Central and West Asia, and in this perspective, we highlight the existing infrastructure and expertise across seven countries (Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Tajikistan, and Uzbekistan) and propose opportunities for enhanced collaboration along with a bold proposal for establishing a new-build, regional vaccine translational research institute to facilitate the development of a robust, regional vaccine R&D environment to combat existing and future health challenges. |
| first_indexed | 2024-04-10T06:18:40Z |
| format | Article |
| id | doaj.art-8fa92b65d97e45e281efd6ec387db762 |
| institution | Directory Open Access Journal |
| issn | 2296-2565 |
| language | English |
| last_indexed | 2024-04-10T06:18:40Z |
| publishDate | 2023-03-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Public Health |
| spelling | doaj.art-8fa92b65d97e45e281efd6ec387db7622023-03-02T05:18:35ZengFrontiers Media S.A.Frontiers in Public Health2296-25652023-03-011110.3389/fpubh.2023.11437901143790Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programsJonathan Hare0Giovanna Riggall1Alexander Bongers2Kirthi Ramesh3Larissa Kokareva4Brian Chin5Crown Agents, London, United KingdomCrown Agents, London, United KingdomCrown Agents, London, United KingdomAsian Development Bank, Manila, PhilippinesCrown Agents, London, United KingdomAsian Development Bank, Manila, PhilippinesThe ability to support a comprehensive vaccine research and development (R&D) portfolio from a health security perspective has taken on enhanced significance over the past 3 years whereby countries that had existing vaccine R&D infrastructure (G7, Russia and China) have been at the forefront of global efforts to combat COVID-19. Few countries outside of these key players have the infrastructure necessary to develop national vaccine programs, though this is beginning to change with investment across many low- and middle-income countries. These same opportunities exist for countries in Central and West Asia, and in this perspective, we highlight the existing infrastructure and expertise across seven countries (Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Tajikistan, and Uzbekistan) and propose opportunities for enhanced collaboration along with a bold proposal for establishing a new-build, regional vaccine translational research institute to facilitate the development of a robust, regional vaccine R&D environment to combat existing and future health challenges.https://www.frontiersin.org/articles/10.3389/fpubh.2023.1143790/fullvaccinesresearchLMICcapacitydevelopmentCentral Asia |
| spellingShingle | Jonathan Hare Giovanna Riggall Alexander Bongers Kirthi Ramesh Larissa Kokareva Brian Chin Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs Frontiers in Public Health vaccines research LMIC capacity development Central Asia |
| title | Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs |
| title_full | Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs |
| title_fullStr | Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs |
| title_full_unstemmed | Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs |
| title_short | Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs |
| title_sort | vaccine research and development capacity in central and west asia a path toward sustainable vaccine r d programs |
| topic | vaccines research LMIC capacity development Central Asia |
| url | https://www.frontiersin.org/articles/10.3389/fpubh.2023.1143790/full |
| work_keys_str_mv | AT jonathanhare vaccineresearchanddevelopmentcapacityincentralandwestasiaapathtowardsustainablevaccinerdprograms AT giovannariggall vaccineresearchanddevelopmentcapacityincentralandwestasiaapathtowardsustainablevaccinerdprograms AT alexanderbongers vaccineresearchanddevelopmentcapacityincentralandwestasiaapathtowardsustainablevaccinerdprograms AT kirthiramesh vaccineresearchanddevelopmentcapacityincentralandwestasiaapathtowardsustainablevaccinerdprograms AT larissakokareva vaccineresearchanddevelopmentcapacityincentralandwestasiaapathtowardsustainablevaccinerdprograms AT brianchin vaccineresearchanddevelopmentcapacityincentralandwestasiaapathtowardsustainablevaccinerdprograms |